Trasylol Renal Failure Lawsuit

FDA Recalls Trasylol – Cites Increased Renal Damage and Failures

On November 5, 2007, the FDA recalls Trasylol from the market due to seriously increased risks of renal damage, renal failure, heart attacks and strokes (see FDA Trasylol Recall). The FDA recall of Trasylol stems from Dr. Dennis Mangano's latest findings, in which he concluded that 22,000 cardiac patients could have been saved if Trasylol had been taken off the market in January 2006 when his Trasylol side effects study was first published. Dr. Dennis Mangano's study found that Trasylol increased the risk of Trayslol-related renal damage, renal failure, Trasylol-related heart attacks, Trasylol-related strokes and death in heart bypass patients. It is estimated that Trasylol damages costs over $1 billion in health care every year. Most heart surgery patients don't know if they were given Trasylol during their open heart surgery until an investigation into their records is conducted after the Trasylol renal damage side effects are discovered.

Bayer's Failure to Disclose Trasylol Renal Failure Results to FDA

On September 21, 2006 the FDA's Cardiovascular and Renal Drug Advisory Committee met to evaluate current data regarding Trasylol side effects. On September 29, 2006, the FDA issued a public health advisory stating that it had new information that Bayer failed to disclose an earlier study that it had conducted involving 67,000 heart surgery patients. Preliminary review of this study suggested that Trasylol side effects included higher risks for stroke, congestive heart failure, renal damage, and death. Bayer failed to disclose the existence of the Trasylol study during the Advisory Committee on September 21, 2006 and continued to market Trasylol for use in cardiac procedures knowing about severe Trasylol renal failure.

Symptoms of Trasylol Renal Failure

Renal failure from Trasylol prevents the renals from functioning as they should. Renals filter waste and fluids from your blood and when they cease to function at normal levels or at all, they leave hazardous levels of toxins in the body. Trasylol renal failure can occur after any cardiovascular procedure or by-pass surgery whereby Trasylol is administered and the blood vessels or renals are blocked. Symptoms of Trasylol renal failure may include bleeding in the stomach or intestines, fluid retention, confusion, seizures, and in severe cases, comas. Trasylol renal failure is a serious and potentially life threatening condition and in severe cases must be treated by dialysis. Renal dialysis operates as an artificial means of removing waste and excess fluid from the blood when the renals are compromised.

Trasylol Renal Failure Lawsuit

If you or a loved one has been diagnosed with renal damage or renal failure following a cardiac catherization, a heart bypass surgery or any other cardiac operation, then call our offices to discuss your legal rights to a possible Trasylol renal failure lawsuit. Talk to a Board Certified Personal Injury Trial Lawyer and get your questions answered. Contact our law firm today.

Click Here for a Free Trasylol Case Evaluation